• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

CMS

Medtronic announces recent reimbursement wins for CGMs in a number of geographies

March 14, 2022 By Sean Whooley

Medtronic (NYSE:MDT) announced today that reimbursement for its CGMs has been expanded or initiated across a number of countries. Earlier this month, the Ontario, Canada provincial government announced a comprehensive reimbursement program for continuous glucose monitoring (CGM) for eligible residents who have type 1 diabetes, adding to a similar program for those with type 1 […]

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Medicare, Patient Monitoring Tagged With: Centers for Medicare and Medicaid Services (CMS), CMS, Medtronic

Pear Therapeutics advances in efforts to get CMS to cover prescription digital therapeutics

February 28, 2022 By Sean Whooley

Pear Therapeutics (NSDQ:PEAR) announced that the Centers for Medicare & Medicaid Services (CMS) established new coding relevant to its prescription digital therapeutics (PDTs). CMS established a new Level II Healthcare Common Procedure Coding System (HCPCS) code to describe prescription digital behavioral therapy — FDA-cleared — per course of treatment, which extends to PDTs including Pear’s reSET, […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Health Technology, Medicare, News Well, Software / IT Tagged With: Centers for Medicare and Medicaid Services (CMS), CMS, Pear Therapeutics

CMS puts final nail in MCIT payment proposal for breakthrough devices

November 12, 2021 By Jim Hammerand

The U.S. Centers for Medicare & Medicaid Services (CMS) rescinded the Medicare Coverage of Innovative Technology (MCIT) and definition of “Reasonable and Necessary” final rule today. CMS said it intends to explore ways to improve the coverage process for better access to innovative and beneficial medical devices, including a process for the Medicare program to […]

Filed Under: Blog, Business/Financial News, Featured, Food & Drug Administration (FDA), Medicare, News Well, Regulatory/Compliance Tagged With: Centers for Medicare and Medicaid Services (CMS), CMS

Senators urge CMS to create payment program for breakthrough devices

November 8, 2021 By Jim Hammerand

Ten U.S. senators are calling on the U.S. Centers for Medicare & Medicaid Services (CMS) to create a new rule allowing government payments for medical devices designated as breakthroughs by the FDA. CMS said in September that it would not move forward with the Medicare Coverage for Innovative Technologies (MCIT) rule, citing safety concerns for […]

Filed Under: Food & Drug Administration (FDA), Medicare, Regulatory/Compliance Tagged With: CMS, FDA

CMS aborts launch of MCIT payment program for breakthrough devices

September 16, 2021 By Jim Hammerand

CMS intends to kill the Medicare Coverage of Innovative Technology (MCIT) program that would have accelerated government payments for medical devices designated by the FDA as breakthroughs. CMS (the U.S. Centers for Medicare & Medicaid Services) disclosed its proposal in the Federal Registrar yesterday — three months before the rule was set to take effect […]

Filed Under: Food & Drug Administration (FDA) Tagged With: Centers for Medicare and Medicaid Services (CMS), CMS, FDA

Senate confirms new CMS leader

May 25, 2021 By Sean Whooley

The U.S. Senate today confirmed President Joe Biden’s selection to lead CMS, Chiquita Brooks-LaSure, with a 55-44 vote in favor. Brooks-LaSure will be the first Black woman to hold the position, according to Senate Majority Leader Chuck Schumer (D-N.Y.) on Twitter. She previously served in the U.S. Dept. of Health and Human Services during the […]

Filed Under: Business/Financial News, Featured, Healthcare Reform, Legal News, Medicare Tagged With: Centers for Medicare and Medicaid Services (CMS), CMS, Dept. of Health & Human Services (HHS), Joe Biden

Boston Scientific, Stryker may get extension on Medicare payments

April 28, 2021 By Sean Whooley

CMS has issued a proposal for the 2022 fiscal year that would potentially help big medtech companies like Boston Scientific and Stryker. Released yesterday, the proposal for the Medicare Hospital Inpatient Prospective Payment System (IPPS) and Long Term Care Hospital (LTCH) offers updated Medicare payment policies and rates for operating and capital-related costs of acute […]

Filed Under: Business/Financial News, Drug-Device Combinations, Drug-Eluting Stents, Featured, Medicare, Orthopedics, Spine, Stents Tagged With: Boston Scientific, Centers for Medicare and Medicaid Services (CMS), CMS, coronavirus, COVID-19, Stryker

CMS delays shift to new payment model for chronic kidney disease treatments

March 12, 2021 By Chris Newmarker

CMS will now wait until Jan. 1, 2022 to start its Kidney Care Choices model, meant to shift the way the U.S. treats chronic kidney disease. The new payment model was supposed to start on Jan. 1 of this year, but health providers are still grappling with the COVID-19 pandemic. The new model could have […]

Filed Under: Dialysis, Featured, Healthcare Reform Tagged With: Centers for Medicare and Medicaid Services (CMS), CMS, DaVita Inc., Fresenius Medical Care, Reimbursement

CMS consolidates coverage for Intersect ENT’s corticosteroid-eluting implant

March 8, 2021 By Sean Whooley

Intersect ENT (NSDQ:XENT) announced today that it received consolidated Medicare coverage for its Sinuva sinus implant. Menlo Park, Calif.-based Intersect ENT said in a news release that CMS published an average selling price (ASP) for the Sinuva implant, providing predictability, transparency and confidence of reimbursement for providers and payers in the future. Get the full story […]

Filed Under: Business/Financial News, Drug-Device Combinations, Implants, Medicare, Otolaryngology/Ear, Nose & Throat (ENT) Tagged With: Centers for Medicare and Medicaid Services (CMS), CMS, Intersect ENT

Ambu, Boston Sci execs see domination for single-use scopes

September 11, 2020 By Tom Salemi

Hospital closures connected to COVID-19 have cut into the sales of many medical device companies, but executives at rival makers of single-use scopes say pandemic has only heightened existing concerns about contamination, exposure and cost. In interviews in this week’s DeviceTalks Weekly Podcast, executives from Ambu A/S  and Boston Scientific (NYSE:BSX)  said improved technology make […]

Filed Under: Endoscopic, Featured Tagged With: Ambu, Bardy Diagnostics, Boston Scientific, Centers for Medicare and Medicaid Services (CMS), CMS, Donald Trump, Elizabeth Holmes, Joe Biden, Kevin Hykes, Theranica Bio-Electronics, Theranos

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS